Severe eosinophilic asthma with paradoxal worsening T2 bronchial inflammation despite sequencial treatment with mepolizumab and benralizumab

C. Marcot (STRASBOURG, France), N. Khayath (STRASBOURG, France), F. De Blay (STRASBOURG, France), N. Migueres (Strasbourg, France)

Source: International Congress 2022 – Clinical problems and management of airway diseases

Session: Clinical problems and management of airway diseases
Session type: Thematic Poster
Number: 1653

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Marcot (STRASBOURG, France), N. Khayath (STRASBOURG, France), F. De Blay (STRASBOURG, France), N. Migueres (Strasbourg, France). Severe eosinophilic asthma with paradoxal worsening T2 bronchial inflammation despite sequencial treatment with mepolizumab and benralizumab. 1653

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.